Company Profile

StemMed LTD
Profile last edited on: 12/3/19      CAGE: 5T6P3      UEI:

Business Identifier: Breast cancer treatment
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

7000 Fannin Street Suite 2110
Houston, TX 77030
   (832) 413-1362
Location: Single
Congr. District: 02
County: Harris

Public Profile

Founded by Baylor College of Medicine faculty members with an exclusive license from the Baylor College of Medicine, StemMed is a pharmaceutical development and testing company adddressing advancement of the treatment of breast cancer through novel insights into the biology of the stem cells that cause the disease. Research shows that only a small subset of the heterogeneous cells within a malignant tumor are responsible for the initiation and maintenance of tumor growth. Therefore, StemMed principals judge firm that specifically targeting such cells for therapeutic intervention will inhibit tumor formation, growth and metastasis. Management judge that this approach may be particularly effective in the treatment of cancers that are resistant to conventional therapies

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2017 2 NIH $1,714,825
Project Title: Oral Small Molecule STAT3 Inhibitor to Treat Cachexia in Chronic Kidney Disease
2013 1 NIH $416,395
Project Title: Chemical Probes That Target Stat3 to Treat Cancer

Key People / Management

  Jenny C Chang -- President

  Michael Lewis

  David J Tweardy